Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02966509
Other study ID # EPAC1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2013
Est. completion date December 2016

Study information

Verified date October 2018
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Engagement of Patients with Advanced Cancer is an intervention that utilizes well-trained lay health coaches to engage patients and their families in goals of care and shared decision-making after a diagnosis of advanced cancer. Although lay health workers have never been tested in this role, we hypothesize that lay health workers can feasibly improve goals of care documentation and help to reduce unwanted healthcare utilization at the end of life for Veterans diagnosed with new advanced stages of cancer and those diagnosed with recurrent disease.


Description:

VAPAHCS proposes to implement and evaluate several critical elements to be in alignment with the VHA's Strategic Goal and priority areas for FY2013. The Engagement of Patients with Advanced Cancer project is an innovative program that will strengthen provider-patient relationship and facilitate whole person care about matters important to Veterans with cancer and important to support network and family. The project is intended to help establish Goals of Care Plan with appropriate documentation, develop, deploy, and evaluate a model of care for persons with cancer that is intended to improve clinical outcomes and experience of care for individuals with advanced cancer who have advanced cancer (stages III, IV or recurrent disease). The intervention provides patients with lay health coaches who assist patients and their families in discussing goals of care and engage in shared-decision making. The goal of the project is to demonstrate that there is improved patient experiences, outcomes, and that the program helps to reduce utilization of health care resources at the end of life.


Recruitment information / eligibility

Status Completed
Enrollment 213
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Newly diagnosed stage III or IV cancer

- Recurrent disease (any stage)

- Ability to consent to study

Exclusion Criteria:

- Patients who are unable to consent to study procedures

Study Design


Related Conditions & MeSH terms

  • Advanced Cancer
  • Cancer of Unknown Origin
  • Carcinoma
  • Carcinoma, Renal Cell
  • Colon Cancer
  • End of Life
  • Gastric Cancer
  • Glioblastoma
  • Glioblastoma Multiforme
  • Head and Neck Neoplasms
  • Kidney Cancer
  • Kidney Neoplasms
  • Liver Cancer
  • Liver Neoplasms
  • Lung Neoplasm
  • Lung Neoplasms
  • Melanoma
  • Neoplasms
  • Neoplasms, Unknown Primary
  • Prostate Cancer
  • Rectal Neoplasms
  • Rectum Cancer
  • Stomach Neoplasms
  • Testicular Neoplasms

Intervention

Behavioral:
EPAC
Each patient will receive a lay health worker who will engage and educate patients on goals of care documentation and will continue to address goals of care for at least 6 months with patients after enrollment in the study.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Stanford University VA Palo Alto Health Care System

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Completed Goals of Care Documentation. We Will Evaluate if 75% of Patients in the Intervention Arm Have a Documented Goals of Care Titled Medical Note Within 6 Months of Patient Enrollment in the Study. Feasibility is defined as at least 75% of patients in the intervention arm with a documented Goals of Care titled medical note within 6 months of patient enrollment in the study. 6 months after each patient enrollment
Secondary Emergency Department Visit (Chart Review) Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment. 6 months after patient enrollment
Secondary Emergency Department Visit (Chart Review) Emergency Department Use for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment. 15 months after patient enrollment
Secondary Hospitalization Visits (Chart Review) Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment. 6 months after patient enrollment
Secondary Hospitalization Visits (Chart Review) Hospitalization use for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment. 15 months after patient enrollment
Secondary Hospice Referral (Chart Review) Hospice referral for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment. 6 months after patient enrollment
Secondary Palliative Care Referral (Chart Review) Palliative Care Referral for each patient will be abstracted by electronic medical record chart review for each patient at 6 months after enrollment. 6 months after patient enrollment
Secondary Palliative Care Referral (Chart Review) Palliative Care Referral for each patient will be abstracted by electronic medical record chart review for each patient at 15 months after enrollment. 15 months after patient enrollment
Secondary Change in Patient Satisfaction With Care Using the Consumer Assessment of Health Care Providers and Systems -General Survey Each patient will receive a satisfaction with care survey (The Consumer Assessment of Health Care Providers and Systems - General (CAHPS)) at baseline and 6 months. We will measure the change in satisfaction from baseline to 6 months. Scores for satisfaction were assessed using the Consumer Assessment of Healthcare Providers and Systems-General survey question #18 which measured rating of health provider, on which scores range from 0 to 10, with higher ratings correspond to higher patient satisfaction. Scores for each group are averaged at baseline and at 6 months. Change in Patient Satisfaction with Care from baseline to 6 months.
Secondary Patient Satisfaction With Decision-Making Using the Satisfaction With Decision Survey Each patient will receive a validated satisfaction with decision-making survey (The Satisfaction with Decision Survey) at 6 months after study enrollment.Satisfaction with Decision was assessed with the use of the 6-question Satisfaction with Decision Scale, on which scores range from 0 to 5, with higher scores indicating better satisfaction with decision-making. Scores for each group are averaged at 6 months after study enrollment. 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A